Movatterモバイル変換


[0]ホーム

URL:


CN103865846B - A kind of faecium and preparation method thereof - Google Patents

A kind of faecium and preparation method thereof
Download PDF

Info

Publication number
CN103865846B
CN103865846BCN201410067604.8ACN201410067604ACN103865846BCN 103865846 BCN103865846 BCN 103865846BCN 201410067604 ACN201410067604 ACN 201410067604ACN 103865846 BCN103865846 BCN 103865846B
Authority
CN
China
Prior art keywords
faecium
animal
bacterium
bacterial strain
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410067604.8A
Other languages
Chinese (zh)
Other versions
CN103865846A (en
Inventor
刘艳玲
于瑞奎
潘剑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu lvmu ecological environmental protection Co., Ltd
Original Assignee
YANGZHOU LYUBAO BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YANGZHOU LYUBAO BIOLOGICAL SCIENCE & TECHNOLOGY Co LtdfiledCriticalYANGZHOU LYUBAO BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201410067604.8ApriorityCriticalpatent/CN103865846B/en
Publication of CN103865846ApublicationCriticalpatent/CN103865846A/en
Application grantedgrantedCritical
Publication of CN103865846BpublicationCriticalpatent/CN103865846B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Landscapes

Abstract

A kind of faecium and preparation method thereof, relates to microorganism field, is specifically related to a kind of faecium and application thereof.From the Rumen of butchering, gather bacterium sample, the condition of outer employing 37 ± 5 DEG C, anaerobism, lucifuge carries out directive breeding, and repeatedly being rule after separation and purification by agar plate subregion obtains faecium L-01.Faecium L-01 can be used as the application of animal microorganism fodder additives, can effectively suppress animal digestive tract pathogenic bacterium, improve digestive tube micro-ecological environment; Strengthen the immunologic function of animal body, and can be used as Substitutes For Antibiotic, can effectively solve current faced serious situation.

Description

A kind of faecium and preparation method thereof
Technical field
The present invention relates to microorganism field, be specifically related to a kind of faecium and application thereof.
Background technology
The current appearance due to abuse of antibiotics and superbacteria etc. series of problems, make that the mankind are unavoidable faces serious situation caused thus, the task of top priority, Substitutes For Antibiotic must be researched and developed as early as possible, provide reliable technical guarantee for green, safety, efficiently animal-feed and human food prods produce.Probiotics is the nearly 20 years a kind of novel fodder additives grown up, and it has the function of microbiotic and enzyme.Probiotics can be supplemented with bacteria group, improves archenteric flora balance, prevention and therapy dysbacteriosis; Can body immune system be stimulated, improve animal body immunological competence; Flora struggle for existence can be participated in, assist body to eliminate toxin and meta-bolites; Can organism metabolism be improved, supplement body nutritive ingredient, promote growth of animals or poultry.
Faecium (enterococcusfaecium) be the current Ministry of Agriculture make (2013 No. 2045) animal microorganism fodder additives hurdle allow the probiotic bacterium kind that uses, research shows that this bacterium can be used as the application of animal microorganism fodder additives, can effectively suppress animal digestive tract pathogenic bacterium, improve digestive tube micro-ecological environment; Strengthen the immunologic function of animal body.
Summary of the invention
The present invention seeks to appearance etc. the series of problems in order to the abuse and superbacteria solving current antibiotic, propose a kind ofly to be beneficial to the faecium L-01 improving animal body metabolism, supplement body nutritive ingredient, promote growth of animals or poultry.
The present invention propose faecium L-01 (enterococcusfaeciuml-01) be preserved in May 30 in 2012 China typical culture collection center being positioned at Wuhan, China university, deposit number is CCTCCNO:M2012194.
The present invention also proposes the preparation method of above faecium L-01, namely from the Rumen of butchering, bacterium sample is gathered, the condition of outer employing 37 ± 5 DEG C, anaerobism, lucifuge carries out directive breeding, and repeatedly being rule after separation and purification by agar plate subregion obtains faecium L-01.
Cud separation after the present invention butchers from healthy goat, purifying, cultivate, identify 1 Enterococcus faecalis and conservation, can be used as the application of animal microorganism fodder additives, can effectively suppress animal digestive tract pathogenic bacterium, improve digestive tube micro-ecological environment; Strengthen the immunologic function of animal body, and can be used as Substitutes For Antibiotic, can effectively solve current faced serious situation.
The present invention screens the bacterial strain obtained, originate from existing bacterial classifications of national conservation mechanism such as Chinese industrial Microbiological Culture Collection administrative centers and biological characteristics different.Through the qualification of Chinese industrial Microbiological Culture Collection administrative center, this bacterial strain is faecium, and has carried out genetic stability test in Chinese industrial Microbiological Culture Collection administrative center, proves this bacterial strain proterties Absorbable organic halogens heredity.In the enzyme activity dynamic changing process of 8-12h, alpha-amylase activity and α-glucose transglucosidase vigor all reach peak value and maintain higher level.
Healthy Rumen after this strains separation is derived from and butchers, its tunning is applied to cultivated animals as animal microorganism fodder additives, especially to improving ruminating animal, its consistency and effect ideal, in addition, the foundation for piglet digestive micro-ecological environment stable state also has positive regulating and controlling effect.
Accompanying drawing explanation
Fig. 1 is the bacterial strain bacterium colony photo of faecium L-01 of the present invention.
Fig. 2, Fig. 3 are respectively the bacterial strain field emission scanning electron microscope photo of faecium L-01 of the present invention.
Fig. 4 is faecium L-01 bacterial strain MRS substratum thalli morphology photo of the present invention.
Fig. 5 is faecium L-01 bacterial strain MRS substratum colonial morphology photo of the present invention.
Fig. 6 is 39 DEG C of time dependent graphs of a relation of amylase (AMS) vigor.
Fig. 7 is the canonical plotting of p-NP.
Fig. 8 is 58 DEG C of time dependent graphs of a relation of α-glucose transglucosidase vigor.
To be faecium L-01 to the 16SrDNA sequential system of relevant kind grow Fig. 9 sets.
Figure 10 is that faecium L-01 plants to relevantpheSgene order phylogenetic tree.
Embodiment
One, the screening of bacterial strain
1. screening process
Bacterium sample is gathered from the cud that the goat raised is butchered, the specified conditions of external employing 37 ± 5 DEG C, anaerobism, lucifuge carry out directive breeding, tamed to single strain L-01 by the separation and purification of repeatedly ruling of agar plate subregion, study its morphology and biological characteristics.Colony characteristics, electron microscope observation single strain form and related keyword enzyme activity determination is observed by agar plate culture.
The configuration of 1.1 working stocks:
First be equipped with nutritional substrate with following table ratio:
CompositionWeight percent (%)
Corn80
Dregs of beans6
Wheat bran10
Salt1
Stone flour1
Secondary calcium phosphate2
Nutritional substrate 125g(2600r/min pulverizing 1.5min is taken again in the ratio of 5%) mix with water, digestion 1h under electromagnetic oven boiling state, after two-layer gauze extracting twice, after extract 2600r/min liquid making beating 1.5min, 500 order nylon-tissue bag are filtered, finally be settled to 2.5L, obtain working stocks.
1.2 artificial medium compositions: the formula with reference to Russell is improved.
Reductive agent (matching while using): 1NNaOH solution 4mL; Na2s7H2o570mg adding distil water is to 100mL.
Major element: Na2hPO45.70g; NaH2pO46.20g; MgSO47H2o0.60g adding distil water is to 1000mL.
Trace element: CaCl22H2o13.20g; MnCl24H2O10.00g; CoCl26H2o1.00g; FeCl36H2o0.8g adding distil water is to 100mL.
Damping fluid: NaHCO335.00g; NH4hCO34.00g; Adding distil water is to 1000mL.
Nutrient solution is prepared: major element 237mL; Trace element 0.12mL; Damping fluid 237mL; Reductive agent 49.5mL; Glucose 10g, adding distil water is to 1000mL.
1.3 culture medium prescription
Extractum carnis 0.9g, peptone 3g, NaCI1.5g, agar 10.5g, adds working stocks 300mL, supplements artificial medium to 600mL.
The cultural method of 1.4 bacteria distribution purifying
Take above-mentioned solid medium in Erlenmeyer flask according to formula, be placed on universal electric furnace and be heated to boiling, cover ventilative sieve and take out after autoclaving 20min at 121 DEG C, a kind of rhyme scheme in Chinese operas serving as the prelude to a complete score for voices after temperature is down to about 50 DEG C, about 10-20min solidifies.
Bacterium sample is gathered from the cud that the goat raised is butchered, and by this rumen bacteria liquid sterile saline doubling dilution to 10-8power, be then separated with transfering loop picking bacterium liquid sectional streak on solid medium, cultivate in 37 ± 5 DEG C of envrionment temperatures, anaerobism lucifuge, after colony growth goes out, the different bacterium colony of picking proceeds to rule and is separated, until purifying agaric.
2. the Senile Mouse of bacterial strain
Above-mentioned screening obtained strains photo on solid medium, as Fig. 5, MRS substratum, 37 DEG C, is cultivated 1 day, colonial morphology: oyster white, circular, tip-like, and smooth surface, projection are opaque, neat in edge.Oil Microscopic observation is spherical, and diameter is about 0.6 μm, paired or stack arrangement, Gram-positive (as Fig. 4).By 15000 times of S-4800 field emission scanning electron microscope photo this bacterium diameter known about 0.5 ~ 0.8um(as Fig. 2,3).
As seen from Figure 1: this bacterium is visible faint yellow circular small colonies on solid medium.
Two, the qualification of bacterial strain
The molecular biology identification of 1 sequence amplification
The extraction of 1.1 bacterial genomes DNA
Bacterial classification is growth 12 ~ 18h in enrichment liquid body is cultivated, and gets 1.5mL bacterium liquid and is placed in EP pipe, the centrifugal 5min of 5000r/min, extracts bacterial genomes DNA.
The amplimer of 1.2 bacterial strain 16SrDNA:
Use 16SrDNA universal primer to increase, by Dalian, precious biotechnology company limited synthesizes.
Reaction system: 0.25uLTaqDNA polysaccharase, 5uLl0 × PCR reaction buffer, 4uLdNTPMasterMix, luLPrimerF (upstream primer), luLPrimerR (downstream primer), 2uL template DNA, ddH2o supplies 50uL.
PCR reaction conditions: 94 DEG C of denaturation 5min; 94 DEG C of sex change 30S, 55 DEG C of annealing 40S, 72 DEG C extend 90S, 30 circulations; 72 DEG C of ends extend 10min.
The mensuration of the detection of 1.3PCR product and l6SrDNA sequence
After 20g/L agarose gel electrophoresis, observe under ultraviolet lamp, if there is the single band of about 1.5kb, then prove Successful amplification target l6SrDNA sequence.Pcr amplification product is mailed to Shanghai Sangon Biological Engineering Technology And Service Co., Ltd's order-checking, then the 16SrDNA sequence obtained is submitted in NCBI nucleic acid database and carries out BLAST on-line analysis.
2 bacterial strain pheS gene primers and PCR reaction conditions
PheS: primer is synthesized by the precious biotechnology company limited in Dalian.
pheS-21-FCAYCCNGCHCGYGAYATGC;
pheS-22-RCCWARVCCRAARGCAAARCC。
PCR reaction conditions: 94 DEG C of denaturation 5min; 94 DEG C of sex change 30S, 50 DEG C of annealing 40S, 72 DEG C extend 40S, 30 circulations; 72 DEG C of ends extend 10min.
The structure of 3 sequential analyses and genealogical tree
Adopt MEGA4.1 software, ortho position connection method display bacterial classification is grown to relevant sequential system of planting and is set, and carries out the Bootstraps statistical test of 1000 repetitions.
4 identification and analysis results
4.1 faecium L-01 grow to relevant 16SrDNA sequential system of planting and set:
Adopt MEGA4.1 software, ortho position connection method display L-01 and the 16SrDNA phylogenetic tree of relevant kind, carry out the similarity double counting of 1000 times, grows tree node and only show Bootstrap value and be greater than 50% numerical value in figure, (e., Enterococcus).
Shown by Fig. 9 Phylogenetic Analysis: bacterial strain L-01 and enterococcus spp (enterococcussp.) in, multiple kinds are gathered in a phylogeny branch, and sequence homology is more than 98.3%, Qi Zhongyue.faeciumaTCC19434t(DQ411813) sequence homology is up to 99.9%.
Through qualification, the 16SrDNA sequence length of faecium L-01 is 1482bp, and qualification result is enterococcus spp.
4.2 faecium L-01 is to relevant kindpheSgene order phylogenetic tree:
Adopt MEGA4.1 software, ortho position connection method display L-01 and relevant kindpheSphylogenetic Tree, carries out the similarity double counting of 1000 times, grows tree node and only show Bootstrap value and be greater than 50% numerical value in figure.
Shown by Figure 10 Phylogenetic Analysis: bacterial strain L-01 and faecium (enterococcusfaecium) gather in a phylogeny branch, sequence homology is 97.4%, with the sequence homology of other Enterococcus species type strain below 86.6%.
Through qualification, faecium L-01'spheSgene order length is 509bp, and qualification result is faecium.
Three, faecium L-01 bacterial strain enzymic activity dynamic studies
1. the mensuration of alpha-amylase activity in bacterium liquid
Measuring method: iodine-starch colorimetry determination of amylase test kit (Bioengineering Research Institute is built up in Nanjing)
α-amylase (AMS) unit of activity defines: the amylase (AMS) in 100mL bacterium liquid, 39 DEG C with substrate-function 30 minutes, hydrolysis 10mg starch is 1 unit.Alpha-amylase activity changes in time sees that Fig. 6 is known, and in the enzyme activity dynamic changing process of 0-12h, alpha-amylase activity continues to raise in 8-12h dynamic changing process.
2. in bacterium liquid, the mensuration-chromophoric substrate of α-glucose transglucosidase vigor measures α-glucose transglucosidase vigor
Reaction substrate is made with colourless p-NP-alpha-D-glucose glycosides (pNPG), through α-glucose transglucosidase hydrolyzing alpha-1, p-NP (pNP) is discharged after 4-glucoside bond, the latter is yellow in the basic conditions, finally by the criterion of the pNP generation under monitoring 405 or 410nm as the active size of α-Isosorbide-5-Nitrae-glucose transglucosidase.
1) preparation of reagent:
(1) 1.25mmol/L p-NP-alpha-D-glucose glycosides (pNPG) solution: 75.2mgpNPG is dissolved in 200mL
In 0.05mol/L acetate buffer (pH5.6).
(2) 4mmol/L p-NP (pNP) solution: 111.3mgpNP is dissolved in 200mL0.05mol/L acetate buffer (pH5.6).
(3) 0.05mol/L acetate buffer (pH5.6): 16.4g sodium acetate adds 12mL acetic acid, is settled to 1000mL.
(4) 1mol/L sodium carbonate solution.
2) p-NP typical curve is made
Get the p-NP (4mmol/L) of different volumes by upper table respectively, be diluted to a series of concentration with 50mmol/L acetate buffer (pH5.6).Then on spectrophotometer, measure the optical density(OD) at 410nm place, take concentration as X-coordinate, and absorption photometric value is that ordinate zou makes curve.
The typical curve of p-NP is as Fig. 7.
3) mensuration of α-Isosorbide-5-Nitrae-glucose transglucosidase vigor
Get 0.8mL p-NP-alpha-D-glucose glycosides (pNPG) (1.25mmol/L), add 0.2mL bacterium liquid, in 58 DEG C of water-baths, 10min is incubated after rapid mixing, take out the sodium carbonate solution termination reaction also adding 2mL1mol/L immediately, by the optical density(OD) at spectrophotometric determination 410nm wavelength place, typical curve is found the amount being equivalent to p-NP, and calculates enzyme activity.
Enzyme activity unit is defined as: the α-glucose transglucosidase in 1L bacterium liquid, 58 DEG C with p-NP-α-D glucoside effect 10 minutes, the enzyme amount that per minute catalysis is formed required for 1umoL p-NP is 1 unit of activity.
Enzyme activity=(A × n)/(V × t);
V in formula-enzyme liquid measure (mL); N-enzyme liquid extension rate; T-reaction times (min).
α-glucose transglucosidase vigor changes in time sees Fig. 8, and as shown in Figure 8, in the enzyme activity dynamic changing process of 0-12h, α-glucose transglucosidase vigor continues to raise in the dynamic changing process of 8-12h.
Sum up: by above test, prove that faecium L-01 of the present invention has genetic stability good, bacterial strain is energetic, the amylase of secretion and the high characteristic of the enzyme activity of transglucosidase.
Due to above feature, the present invention is expected the fodder additives being applied to preparation animal, cultivated animals, and pig, bird, ruminating animal, aquatic animal, effectively can replace microbiotic, plays diseases prevention, resistant effect.
Lv Bao bio tech ltd, <110> Yangzhou
<120> faecium L-01 and preparation method thereof
<160>2
<210>1
<211>1482
<212>DNA
<213> artificial sequence
<220>
The 16SrDNA sequence of <223> faecium L-01 bacterial strain
<400>1
gacgaacgctggcggcgtgcctaatacatgcaagtcgaacgcttctttttccaccggagc60
ttgctccaccggaaaaagaggagtggcgaacgggtgagtaacacgtgggtaacctgccca120
tcagaaggggataacacttggaaacaggtgctaataccgtataacaatcnaaaccgcatg180
gttttgatttgaaaggcgctttcgggtgtcgctgatggatggacccgcggtgcattagct240
agttggtgaggtaacggctcaccaaggccacgatgcatagccgacctgagagggtgatcg300
gccacattgggactgagacacggcccaaactcctacgggaggcagcagtagggaatcttc360
ggcaatggacgaaagtctgaccgagcaacgccgcgtgagtgaagaaggttttcggatcgt420
aaaactctgttgttagagaagaacaaggatgagagtaactgttcatcccttgacggtatc480
taaccagaaagccacggctaactacgtgccagcagccgcggtaatacgtaggtggcaagc540
gttgtccggatttattgggcgtaaagcgagcgcaggcggtttcttaagtctgatgtgaaa600
gcccccggctcaaccggggagggtcattggaaactgggagacttgagtgcagaagaggag660
agtggaattccatgtgtagcggtgaaatgcgtagatatatggaggaacaccagtggcgaa720
ggcggctctctggtctgtaactgacgctgaggctcgaaagcgtggggagcaaacaggatt780
agataccctggtagtccacgccgtaaacgatgagtgctaagtgttggagggtttccgccc840
ttcagtgctgcagctaacgcattaagcactccgcctggggagtacgaccgcaaggttgaa900
actcaaaggaattgacgggggcccgcacaagcggtggagcatgtggtttaattcgaagca960
acgcgaagaaccttaccaggtcttgacatcctttgaccactctagagatagagcttcccc1020
ttcgggggcaaagtgacaggtggtgcatggttgtcgtcagctcgtgtcgtgagatgttgg1080
gttaagtcccgcaacgagcgcaacccttattgttagttgccatcattcagttgggcactc1140
tagcaagactgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatcatgccc1200
cttatgacctgggctacacacgtgctacaatgggaagtacaacgagttgcgaagtcgcga1260
ggttaagctaatctcttaaagcttttctcagttcggattgcaggctgcaactcgcctgca1320
tgaagccggaatcgctagtaatcgcggatcagcacgccgcggtgaatacgttcccgggcc1380
ttgtacacaccgcccgtcacaccacgagagtttgtaacacccgaagtcggtgaggtaacc1440
ttttgagccagccgcctaaggtgggatagatgattggggtgg
<210>2
<211>509
<212>DNA
<213> artificial sequence
<220>
The pheS gene order of <223> faecium L-01 bacterial strain
<400>2
catattatatatgacccgagtattatcatccgggcccgatatgcaagatactttctatat60
ttcagacgagatattgattcggacacatacttcaccagtccaagcacggacaatggaaaa120
gcatgatttctctaagggtgctctacgaatgatctcgcctggaaaagttttccgcagaga180
tacagatgatgcgacccacagccatcagttccatcaaattgaagggctagttgttgataa240
aaacatcacgatgggcgatcttaaaggaacattagaagtcgtaatgaaaaaaatgtttgg300
ggaagatcgtgaaatccgtttgcgtccaagttatttcccatttacggagccatcagtaga360
agtagatgtcagttgtttcaaatgtggtggtgccggttgtaacgtatgtaaatacactgg420
atggatcgagattttaggagctggcatggtgcacccgaatgtgttgaagatgtcaggaat480
cgatccagaagaatattcaggttttgctt

Claims (1)

CN201410067604.8A2014-02-272014-02-27A kind of faecium and preparation method thereofActiveCN103865846B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201410067604.8ACN103865846B (en)2014-02-272014-02-27A kind of faecium and preparation method thereof

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201410067604.8ACN103865846B (en)2014-02-272014-02-27A kind of faecium and preparation method thereof

Publications (2)

Publication NumberPublication Date
CN103865846A CN103865846A (en)2014-06-18
CN103865846Btrue CN103865846B (en)2016-03-30

Family

ID=50904858

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201410067604.8AActiveCN103865846B (en)2014-02-272014-02-27A kind of faecium and preparation method thereof

Country Status (1)

CountryLink
CN (1)CN103865846B (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US10322151B2 (en)2015-06-152019-06-184D Pharma Research LimitedCompositions comprising bacterial strains
US10391130B2 (en)2015-06-152019-08-274D Pharma Research LimitedCompositions comprising bacterial strains
US10391128B2 (en)2015-11-232019-08-274D Pharma Research LimitedCompositions comprising bacterial strains
US10456444B2 (en)2014-12-232019-10-294D Pharma Research LimitedPirin polypeptide and immune modulation
US10471108B2 (en)2015-11-202019-11-124D Pharma Research LimitedCompositions comprising bacterial strains
US10485830B2 (en)2016-12-122019-11-264D Pharma PlcCompositions comprising bacterial strains
US10493112B2 (en)2015-06-152019-12-034D Pharma Research LimitedCompositions comprising bacterial strains
US10500237B2 (en)2015-06-152019-12-104D Pharma Research LimitedCompositions comprising bacterial strains
US10583158B2 (en)2016-03-042020-03-104D Pharma PlcCompositions comprising bacterial strains
US10610549B2 (en)2016-07-132020-04-074D Pharma PlcComposition comprising bacterial strains
US10610550B2 (en)2015-11-202020-04-074D Pharma Research LimitedCompositions comprising bacterial strains
US10736926B2 (en)2015-06-152020-08-114D Pharma Research LimitedCompositions comprising bacterial strains
US10744166B2 (en)2015-11-232020-08-184D Pharma Research LimitedCompositions comprising bacterial strains
US10851137B2 (en)2013-04-102020-12-014D Pharma Research LimitedPolypeptide and immune modulation
US10987387B2 (en)2017-05-242021-04-274D Pharma Research LimitedCompositions comprising bacterial strain
US11007233B2 (en)2017-06-142021-05-184D Pharma Research LimitedCompositions comprising a bacterial strain of the genus Megasphera and uses thereof
US11013773B2 (en)2011-07-142021-05-254D Pharma Research LimitedLactic acid bacterial strains
US11123379B2 (en)2017-06-142021-09-214D Pharma Research LimitedCompositions comprising bacterial strains
US11123378B2 (en)2017-05-222021-09-214D Pharma Research LimitedCompositions comprising bacterial strains
US11224620B2 (en)2016-07-132022-01-184D Pharma PlcCompositions comprising bacterial strains
US11266698B2 (en)2011-10-072022-03-084D Pharma Research LimitedBacterium for use as a probiotic for nutritional and medical applications
US11723933B2 (en)2014-12-232023-08-15Cj Bioscience, Inc.Composition of bacteroides thetaiotaomicron for immune modulation
US12048720B2 (en)2017-06-142024-07-30Cj Bioscience, Inc.Compositions comprising bacterial strains

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN105296541A (en)*2014-07-302016-02-03无限极(中国)有限公司Oat fermentation liquor, preparation method thereof and application of oat fermentation liquor as cosmetic raw material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN101629155B (en)*2009-04-302012-07-25邵峰Enterococcus faecium
CN102304483A (en)*2011-08-122012-01-04北京金泰得生物科技股份有限公司Enterococcus faecium for feeding and applications thereof
CN102373172B (en)*2011-11-032013-03-20北京龙科方舟生物工程技术有限公司Enterococcus faecium and application thereof
CN102747003B (en)*2011-12-292013-11-13武汉华大瑞尔科技有限公司Screening and application of probiotic Enterococcus faecium

Cited By (42)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US11013773B2 (en)2011-07-142021-05-254D Pharma Research LimitedLactic acid bacterial strains
US11266698B2 (en)2011-10-072022-03-084D Pharma Research LimitedBacterium for use as a probiotic for nutritional and medical applications
US11414463B2 (en)2013-04-102022-08-164D Pharma Research LimitedPolypeptide and immune modulation
US10851137B2 (en)2013-04-102020-12-014D Pharma Research LimitedPolypeptide and immune modulation
US10456444B2 (en)2014-12-232019-10-294D Pharma Research LimitedPirin polypeptide and immune modulation
US10973872B2 (en)2014-12-232021-04-134D Pharma Research LimitedPirin polypeptide and immune modulation
US11723933B2 (en)2014-12-232023-08-15Cj Bioscience, Inc.Composition of bacteroides thetaiotaomicron for immune modulation
US10493112B2 (en)2015-06-152019-12-034D Pharma Research LimitedCompositions comprising bacterial strains
US11040075B2 (en)2015-06-152021-06-224D Pharma Research LimitedCompositions comprising bacterial strains
US10391130B2 (en)2015-06-152019-08-274D Pharma Research LimitedCompositions comprising bacterial strains
US10322151B2 (en)2015-06-152019-06-184D Pharma Research LimitedCompositions comprising bacterial strains
US11273185B2 (en)2015-06-152022-03-154D Pharma Research LimitedCompositions comprising bacterial strains
US10500237B2 (en)2015-06-152019-12-104D Pharma Research LimitedCompositions comprising bacterial strains
US10736926B2 (en)2015-06-152020-08-114D Pharma Research LimitedCompositions comprising bacterial strains
US11331352B2 (en)2015-06-152022-05-174D Pharma Research LimitedCompositions comprising bacterial strains
US10780134B2 (en)2015-06-152020-09-224D Pharma Research LimitedCompositions comprising bacterial strains
US11433106B2 (en)2015-06-152022-09-064D Pharma Research LimitedCompositions comprising bacterial strains
US10864236B2 (en)2015-06-152020-12-154D Pharma Research LimitedCompositions comprising bacterial strains
US11389493B2 (en)2015-06-152022-07-194D Pharma Research LimitedCompositions comprising bacterial strains
US10610550B2 (en)2015-11-202020-04-074D Pharma Research LimitedCompositions comprising bacterial strains
US10471108B2 (en)2015-11-202019-11-124D Pharma Research LimitedCompositions comprising bacterial strains
US11058732B2 (en)2015-11-202021-07-134D Pharma Research LimitedCompositions comprising bacterial strains
US10744166B2 (en)2015-11-232020-08-184D Pharma Research LimitedCompositions comprising bacterial strains
US10391128B2 (en)2015-11-232019-08-274D Pharma Research LimitedCompositions comprising bacterial strains
US10583158B2 (en)2016-03-042020-03-104D Pharma PlcCompositions comprising bacterial strains
US10610549B2 (en)2016-07-132020-04-074D Pharma PlcComposition comprising bacterial strains
US10610548B2 (en)2016-07-132020-04-074D Pharma PlcCompositions comprising bacterial strains
US11224620B2 (en)2016-07-132022-01-184D Pharma PlcCompositions comprising bacterial strains
US10967010B2 (en)2016-07-132021-04-064D Pharma PlcCompositions comprising bacterial strains
US10960031B2 (en)2016-07-132021-03-304D Pharma PlcCompositions comprising bacterial strains
US10485830B2 (en)2016-12-122019-11-264D Pharma PlcCompositions comprising bacterial strains
US10543238B2 (en)2016-12-122020-01-284D Pharma PlcCompositions comprising bacterial strains
US10898526B2 (en)2016-12-122021-01-264D Pharma PlcCompositions comprising bacterial strains
US11123378B2 (en)2017-05-222021-09-214D Pharma Research LimitedCompositions comprising bacterial strains
US11376284B2 (en)2017-05-222022-07-054D Pharma Research LimitedCompositions comprising bacterial strains
US11382936B2 (en)2017-05-222022-07-124D Pharma Research LimitedCompositions comprising bacterial strains
US10987387B2 (en)2017-05-242021-04-274D Pharma Research LimitedCompositions comprising bacterial strain
US11007233B2 (en)2017-06-142021-05-184D Pharma Research LimitedCompositions comprising a bacterial strain of the genus Megasphera and uses thereof
US11660319B2 (en)2017-06-142023-05-304D Pharma Research LimitedCompositions comprising bacterial strains
US11123379B2 (en)2017-06-142021-09-214D Pharma Research LimitedCompositions comprising bacterial strains
US11779613B2 (en)2017-06-142023-10-10Cj Bioscience, Inc.Compositions comprising a bacterial strain of the genus Megasphera and uses thereof
US12048720B2 (en)2017-06-142024-07-30Cj Bioscience, Inc.Compositions comprising bacterial strains

Also Published As

Publication numberPublication date
CN103865846A (en)2014-06-18

Similar Documents

PublicationPublication DateTitle
CN103865846B (en)A kind of faecium and preparation method thereof
CN103275907B (en)Bacillus amyloliquefacien and preparation method and application thereof
CN105039223B (en)One plant has the bacillus subtilis for inhibiting C.perfringens effect and its application
CN101638627B (en)Bacillus subtilis and application thereof in biological feed additives
CN105567598B (en)A kind of Tibetan pig source bacillus amyloliquefaciens and its application
CN103555640B (en)Bacillus subtilis and application thereof to livestock breeding
CN104862254B (en)One Enterococcus faecalis HEW A588 and its application
KR100418016B1 (en)Microorganism composition using as probiotics for growth promoting nutrient
CN105524855B (en)A kind of bacillus coagulans and its application with aquatic pathogenic bacterium antagonistic properties
CN113249255B (en)Bacillus subtilis for preventing and controlling enteritis of poultry and application thereof
JP6667870B2 (en) Rotifer feed
CN104130958A (en)Bacillus subtilis and application of bacillus subtilis in preventing and curing peony root-knot nematode
CN108865946A (en)One plant height ground bacillus and its application in prevention and treatment tomato root-knot eelworm
CN101985605B (en)Saprolegnia antagonist and application thereof
CN112662599A (en)Poultry source Bacillus belgii CL-4 and application thereof
CN102517227A (en)Enterococcus faecalis and applications and feed additive and leavening agent thereof
CN108660097B (en)Screening and application of fish-source enterococcus faecium R8
TW201036551A (en)New pseudomonas bacterium
CN115710566B (en)Strain for comprehensive planting and breeding of rice field and application thereof
JP2019517810A (en) Bacillus licheniformis NY1505 strain producing a large amount of α-glucosidase inhibitor
CN101993843A (en)Bacillus firmus strain and application thereof
CN104087529B (en)bacillus pumilus (Bacillus pumilus) JY2 and application thereof
CN118562772B (en) A crayfish intestinal microecological additive containing low-temperature protease and postbiotic preparations, and a preparation method and application thereof
CN117417853B (en)Moraxella and microbial inoculum prepared from seawater Luo Sailve as well as preparation method and application thereof
CN108865931A (en)One bacillus and its application

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
CB03Change of inventor or designer information

Inventor after:Liu Yanling

Inventor after:Yu Ruikui

Inventor after:Pan Jian

Inventor before:Pan Linfu

CORChange of bibliographic data
C14Grant of patent or utility model
GR01Patent grant
TR01Transfer of patent right
TR01Transfer of patent right

Effective date of registration:20200903

Address after:225127 Jiangsu Province, Yangzhou City Hanjiang Industrial Park in Hanjiang District of China Ganglu No. 8 1

Patentee after:Jiangsu lvmu ecological environmental protection Co., Ltd

Address before:211400, Jiangsu, Yangzhou Province, Yizheng City, Liu town Pangu Industrial Concentration Zone No. 61

Patentee before:YANGZHOU LVBAO BIOLOGICAL TECHNOLOGY Co.,Ltd.


[8]ページ先頭

©2009-2025 Movatter.jp